Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy
Titel:
Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Efficacy results from a randomized phase II clinical trial of one fraction of 19 Gy or two fractions of 13.5 Gy
Auteur:
Morton, Gerard McGuffin, Merrylee Chung, Hans T. Tseng, Chia-Lin Helou, Joelle Ravi, Ananth Cheung, Patrick Szumacher, Ewa Liu, Stanley Chu, William Zhang, Liying Mamedov, Alexandre Loblaw, Andrew